evenfolioETF Details
VanEck·Health·BBH · Nasdaq
VanEck Biotech ETF (BBH)
- Price
- $257.98
- —30 Oct 2026
- Assets
- $487.7M
- Total net assets
- Expense ratio
- 0.35%
- Category 1.00%
- Yield
- 0.39%
- Trailing distributions
- 1Y return
- 45.6%+16.8%
- Category 28.8%
- 3Y CAGR
- 22.0%+0.5%
- Category 21.5%
- 5Y CAGR
- 5.8%+1.7%
- Category 4.1%
Loading NAV history…
VanEck Biotech ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +5.5% | +25.5% | +40.9% | +36.3% | +45.6% | +22.0% | +5.8% | +10.0% | +11.8% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +1.9% | +15.6% | +17.8% | +15.9% | +16.8% | +0.5% | +1.7% | -0.8% | +0.2% |
Holdings
The 10 largest positions make up 72.5% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| AMGN | Amgen Inc | 15.74% |
| GILD | Gilead Sciences Inc | 13.28% |
| VRTX | Vertex Pharmaceuticals Inc | 8.22% |
| REGN | Regeneron Pharmaceuticals Inc | 6.39% |
| MRNA | Moderna Inc | 6.36% |
| NTRA | Natera Inc | 5.32% |
| ARGX | argenx SE ADR | 4.61% |
| IQV | IQVIA Holdings Inc | 4.44% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 4.17% |
| ILMN | Illumina Inc | 3.99% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 28.8
- P/B
- 6.4
- P/S
- 6.5
- P/CF
- 19.5
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks100.0%
ETF details
- Issuer
- VanEck
- Category
- Equity · Health
- Ticker
- BBH
- Exchange
- Nasdaq
- Inception
- 20 Dec 2011 (14.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.35% (category 1.00%)
- Holdings turnover
- 19% (category 51%)
- Distribution yield
- 0.39%
- Beta, 3 years
- 0.56
- Total net assets
- $487.7M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- PBE · Invesco Biotechnology & Genome ETFInvesco · $423.5M · ER 0.59%5Y 6.9%
- PTH · Invesco Dorsey Wright Healthcare Momentum ETFInvesco · $367M · ER 0.60%5Y 2.5%
- PINK · Simplify Health Care ETFSimplify Asset Management · $349M · ER 0.51%5Y 9.7%
- IDNA · iShares Genomics Immunology and Healthcare ETFiShares · $299M · ER 0.47%5Y -2.0%
- XHS · State Street SPDR S&P Health Care Services ETFState Street Investment Management · $218.5M · ER 0.35%5Y 6.4%
- SBIO · ALPS Medical Breakthroughs ETFALPS · $211.6M · ER 0.50%5Y 4.3%